Market Cap | 58.22M | P/E | 152.00 | EPS this Y | - | Ern Qtrly Grth | - |
Income | 816.02k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 2.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 4.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -1.00% |
Recommedations | - | Quick Ratio | 0.40 | Shares Outstanding | 4.64M | 52W Low Chg | 7.00% |
Insider Own | - | ROA | - | Shares Float | 1.38M | Beta | 0.01 |
Inst Own | 15.63% | ROE | - | Shares Shorted/Prior | 1.46K/1.01K | Price | 10.64 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 4,708 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 10 | Change | -0.37% |
PepperLime Health Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in San Francisco, California.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Kepos Capital LP | 10% Owner 10% Owner | Feb 13 | Sell | 10.1408 | 100,000 | 1,014,080 | 86,348 | 02/15/23 |